PEPCK Antibodies

Santa Cruz Biotechnology features a diverse variety of PEPCK monoclonal antibodies for investigating phosphoenolpyruvate carboxykinase (PEPCK) in various biological processes. PEPCK Antibodies for PEPCK are compatible with multiple research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PEPCK is a key enzyme in gluconeogenesis and plays a critical role in glucose metabolism, particularly in the liver and kidney. Its regulation is essential for maintaining glucose homeostasis, especially during fasting or intense exercise. Dysregulation of PEPCK has been implicated in metabolic disorders, making it a significant target for research in diabetes and obesity. PEPCK monoclonal antibodies enable researchers to examine glucose metabolism pathways and their relationship to various diseases. Understanding PEPCK activity and regulation can provide valuable insights into metabolic conditions and potential therapeutic approaches. Investigating PEPCK expression patterns helps reveal its role in different tissues and physiological states. Santa Cruz Biotechnology monoclonal antibodies for PEPCK support researchers worldwide in advancing our understanding of metabolic diseases and potential treatments.